Sarepta adds CMOs ahead of FDA decision; Indian regulator posts GMP guidance;

> Sarepta Therapeutics ($SRPT) added CMOs in anticipation of a possible U.S. launch of its DMD drug. Transcript

> India's Central Drugs Standard Control Organization (CDSCO) published guidance on procedures for GMP inspections. News

> French CMO Unither committed to a $16M expansion of its New York production plant. Article

> Athersys began evaluating Terumo BCT's cell culture system. Release

> Ashland revealed plans to add production capacity for a pharmaceutical tablet binder. Item

And Finally... UniQure ($QURE) leveraged its gene therapy manufacturing prowess to persuade Germany's InoCard to sell up. The Dutch gene therapy specialist is building a 55,000-square-foot production plant in Lexington, MA. Piece